📣 VC round data is live. Check it out!

Cavali ICLV Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cavali ICLV and similar public comparables like Alterna Asesoria, K33, Investimentos Bemge, Capitea and more.

Cavali ICLV Overview

About Cavali ICLV

Cavali ICLV SA is the Peruvian Central Securities and Settlement Depository. The company processes transactions carried out in the stock exchange. The company services include negotiable invoices, services for investors, registration of securities, compensation and liquidation and international services.


Founded

1997

HQ

Peru

Employees

N/A

Financials (FY)

Revenue:
Net Income:

EV

$47M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cavali ICLV Stock Performance

Cavali ICLV has current market cap of $47M, and enterprise value of $47M.


Cavali ICLV's stock price is $1.57.

See more trading valuation data for Cavali ICLV
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$47M$47M1.6%

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cavali ICLV Valuation Multiples

Cavali ICLV Financial Valuation Multiples

As of May 12, 2026, Cavali ICLV has market cap of $47M and EV of $47M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cavali ICLV Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Cavali ICLV Competitors

Cavali ICLV competitors include Alterna Asesoria, K33, Investimentos Bemge, Capitea, Spotlight Group, GreenMerc, Aforti Holding, abc Multiactive, Newport Gold and Alfa Holdings.

Most Cavali ICLV public comparables operate across Other Financial Services.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Alterna Asesoria1.1x9.5x
K330.2x(66.5x)
Investimentos Bemge337.1x(63.1x)
Capitea1.1x1.4x
Spotlight Group1.1x5.4x
GreenMerc2.0x87.2x
Aforti Holding1.1x(89.9x)
abc Multiactive0.9x4.7x

This data is available for Pro users. Sign up to see all Cavali ICLV competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cavali ICLV

When was Cavali ICLV founded?Cavali ICLV was founded in 1997.
Where is Cavali ICLV headquartered?Cavali ICLV is headquartered in Peru.
Is Cavali ICLV publicly listed?Yes, Cavali ICLV is a public company listed on Lima Stock Exchange.
What is the stock symbol of Cavali ICLV?Cavali ICLV trades under CAVALIC1 ticker.
When did Cavali ICLV go public?Cavali ICLV went public in 2007.
Who are competitors of Cavali ICLV?Cavali ICLV main competitors include Alterna Asesoria, K33, Investimentos Bemge, Capitea, Spotlight Group, GreenMerc, Aforti Holding, abc Multiactive, Newport Gold, Alfa Holdings.
What is the current market cap of Cavali ICLV?Cavali ICLV's current market cap is $47M.
Is Cavali ICLV profitable?No, Cavali ICLV is not profitable.
How many companies Cavali ICLV has acquired to date?Cavali ICLV hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cavali ICLV has invested to date?Cavali ICLV hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cavali ICLV

Lists including Cavali ICLV

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial